Baillie Gifford & CO Bridge Bio Pharma, Inc. Transaction History

Baillie Gifford & CO

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 27, 2022	BUY	$7.94 - $12.36 $122,371 - $190,492	15,412 Added 3.18%	499,889 $4.97 Million
Q2 2022 Aug 08, 2022	SELL	$5.21 - $12.14 $299,126 - $697,005	-57,414 Reduced 10.6%	484,477 $4.4 Million
Q1 2022 May 05, 2022	BUY	$7.34 - $17.16 $382,927 - $895,237	52,170 Added 10.65%	541,891 $5.5 Million
Q4 2021 Jan 20, 2022	BUY	$11.38 - $53.41 $271,356 - $1.27 Million	23,845 Added 5.12%	489,721 $8.17 Million
Q3 2021 Oct 19, 2021	BUY	$46.87 - $64.24 $2.16 Million - $2.95 Million	45,984 Added 10.95%	465,876 $21.8 Million
Q2 2021 Aug 02, 2021	BUY	$46.47 - $63.93 $4.98 Million - $6.86 Million	107,247 Added 34.3%	419,892 $25.6 Million
Q1 2021 May 06, 2021	BUY	$55.47 - $72.35 $10.8 Million - $14 Million	194,113 Added 163.76%	312,645 $19.3 Million
Q4 2020 Feb 10, 2021	BUY	$38.38 - $71.11 $2.23 Million - $4.13 Million	58,063 Added 96.02%	118,532 $8.43 Million
Q3 2020 Nov 12, 2020	BUY	$27.2 - $42.19 $1.49 Million - $2.31 Million	54,660 Added 940.95%	60,469 $2.27 Million
Q2 2020 Aug 12, 2020	BUY	$22.22 - $35.69 $69,081 - $110,960	3,109 Added 115.15%	5,809 $189,000
Q1 2020 May 08, 2020	BUY	$16.11 - $36.23 $43,497 - $97,820	2,700 New	2,700 $78,000

291

171M

10.4M

2.37M

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $3.42B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

Get notified when there are updates to the investment portfolio of Baillie Gifford & CO, based on Form 13F filings with the SEC.

Stay updated on Baillie Gifford & CO with notifications on news.